RadNet, Inc. (RDNT) Tops Q1 EPS by 3c; Boosts FY14 adj.-EBITDA Outlook

RadNet, Inc. (NASDAQ: RDNT) reported Q1 EPS of ($0.03), $0.03 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $168.9 million versus the consensus estimate of $173.53 million.

Aggregate and same-center procedural volumes were negatively impacted from the sever east coast weather conditions. For the first quarter of 2014, as compared to the prior year's first quarter, MRI volume decreased 0.7%, CT volume was flat and PET/CT volume decreased 2.7%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased 0.4% over the prior year's first quarter. On a same-center basis, including only those centers which were part of RadNet for both the first quarters of 2014 and 2013, MRI volume decreased 0.8%, CT volume decreased 1.2% and PET/CT volume decreased 2.7%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased 1.1% over the prior year's same quarter.

Boosts FY14 adjusted EBITDA outlook by $2 million to a range of $112 to $122 million.

For earnings history and earnings-related data on RadNet, Inc. (RDNT) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Why UBS thinks this European chipmaker is still undervalued despite its premium valuation
• Profound Medical names Richard Fabian as president